The most common way to understand the impact of a disease is to track its rates of prevalence and mortality because these metrics are derived from easily collected data. However, prevalence and mortality rates fail to capture whether a disease is becoming more dangerous without necessarily becoming more directly deadly.
This report uses multiple-cause mortality data for the universe of US death certificates from 2006 to 2019 to explore the distribution of factors contributing to death. We examine the role of “metabolic illnesses,” broadly defined as illnesses that occur due to abnormalities in the body’s metabolic process. Although these illnesses all impact the same system, they may have very different causes, presentations, risk factors, and impacts on quality of life.
We explore how these contributors changed in frequency for all causes of death and for each of the top causes of death in the United States between 2006 and 2019. We also examine how these changes differed based on sex, race, and ethnicity.

Andrew Friedson

Katherine Sacks
Related Content
-
Citi's Christopher Hite Joins FasterCures Advisory Board
Hite’s decades of healthcare finance experience will enhance center’s approach to biomedical innovation WASHINGTON, August 13, 2019 – FasterCures, a center of the Milken Institute, today announced the appointment of Christopher Hite, Vice...Read Article -
Milken Institute Global Conference Scheduled for October 17-20, 2021
Los Angeles – April 15, 2021 – The Milken Institute Global Conference, an annual convening of global leaders in government, finance, health, academia, and philanthropy, will take place this fall from October 17-20, 2021 at The Beverly...Milken Institute Global Conference Scheduled for October 17-20, 2021
-
2023-2026 National Health Security Strategy (NHSS)
Submitted electronically Ms. Dawn O’Connell Assistant Secretary for Preparedness and Response HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) 200 Independence Ave. Washington, DC 20201 Re: 2023-2026 National...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives. -
Patient-Reported Outcomes: Design with the End in Mind
“What outcomes matter to patients?” This question is asked at nearly every meeting in biomedical R&D and health care. As FasterCures has documented over the years, there is a big change afoot to place patients in the center of medical...Read Report -
Obesity in the Workplace: What Employers Can Do Differently
The Milken Institute Center for Public Health (the Center) focuses on chronic disease research, policy evaluation, and thought leadership by convening experts and stakeholders. As part of this work, the Center aims to change the public’s...Read Report -
America's Obesity Crisis: The Health and Economic Costs of Excess Weight
This study calculates the prevalence and economic effects of diseases related to obesity and overweight in the United States. These costs are paid by individuals and their households, employers, government, and society. The prevalence of...Read Report11 11Hugh Waters and Marlon Graf -
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical innovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not...Read Report -
Request for Proposals: Misophonia
The Misophonia Research Fund is pleased to release the 2023 Request for Proposals. The General Grant Program RFP is soliciting research proposals that aim to characterize misophonia, develop objective methods to assess misophonia, or...Read Report -
The Impact of Insight: Patient Preferences in Novel Screening Technologies for Cancer
Patient preferences and insights are increasingly considered throughout the medical product life cycle in addition to clinical outcomes. We know that incorporating patient preferences in the product life cycle can create meaningful results...Patient preferences and insights are increasingly considered throughout the medical product life cycle in addition to clinical outcomes. We know that incorporating patient preferences in the product...
11Katie O'Connor and Hadly Clark -
Coalition-Building Between the US and China on Women’s Cancer Detection, Treatment, and Care
Cancer is one of the leading causes of death in the US and China. Of the top 10 (by incidence) cancers in China, four are women’s cancers, including breast and cervical cancers. Despite successes in cancer control and prevention in both...Read Report -
Defining and Demonstrating the Value of Patient Engagement in Medtech Research and Product Development
In 2022, FasterCures published a report titled The Current Landscape of the Science of Patient Input, which examined the progress of patient engagement (PE) in biomedical research and identified ways to overcome ongoing challenges. Building...Read Report -
Raleigh, NC and Gainesville, GA Top Milken Institute’s 2025 Annual Ranking of Best-Performing Cities
January 14, 2025 (Los Angeles, CA)—Raleigh, NC is the best-performing large metropolitan area, according to the 2025 Milken Institute Best-Performing Cities (BPC) report, taking the top spot in the rankings following two consecutive years...Read ArticleImagePaul Guequierre
Director, Strategic CommunicationsPaul Guequierre is the director of strategic communications. In this role, he works to increase the profile of Milken Institute in the media, raise the visibility of issues important to the organization and its stakeholders, and expand the Institute's digital presence.